106 related articles for article (PubMed ID: 10956388)
1. Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA.
Bryan EJ; Thomas NA; Palmer K; Dawson E; Englefield P; Campbell IG
Int J Cancer; 2000 Sep; 87(6):798-802. PubMed ID: 10956388
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.
Hatta Y; Takeuchi S; Yokota J; Koeffler HP
Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043
[TBL] [Abstract][Full Text] [Related]
3. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
Bryan EJ; Watson RH; Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):719-21. PubMed ID: 8631002
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
[TBL] [Abstract][Full Text] [Related]
5. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at 7q22 and mutation analysis of the CDP gene in human epithelial ovarian tumors.
Neville PJ; Thomas N; Campbell IG
Int J Cancer; 2001 Feb; 91(3):345-9. PubMed ID: 11169958
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the BRCA2 gene in ovarian carcinomas.
Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J
Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
Englefield P; Foulkes WD; Campbell IG
Br J Cancer; 1994 Nov; 70(5):905-7. PubMed ID: 7947096
[TBL] [Abstract][Full Text] [Related]
10. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
[TBL] [Abstract][Full Text] [Related]
12. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.
Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK
J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439
[TBL] [Abstract][Full Text] [Related]
13. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
14. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
15. Absence of PPP2R1B gene alterations in primary ovarian cancers.
Campbell IG; Manolitsas T
Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.
Wu R; Connolly DC; Ren X; Fearon ER; Cho KR
Neoplasia; 1999 Oct; 1(4):311-4. PubMed ID: 10935485
[TBL] [Abstract][Full Text] [Related]
17. BamHI polymorphism at N-acetyl-alpha-galactosaminidase locus (NAGA).
Yamauchi T; Tanaka H; Hiraiwa M; Uda Y; Miyatake T; Tsuji S
Nucleic Acids Res; 1991 May; 19(9):2518. PubMed ID: 1675010
[No Abstract] [Full Text] [Related]
18. Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.
Yanaihara N; Nishioka M; Kohno T; Otsuka A; Okamoto A; Ochiai K; Tanaka T; Yokota J
Int J Cancer; 2004 Oct; 112(1):150-4. PubMed ID: 15305387
[TBL] [Abstract][Full Text] [Related]
19. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.
Foulkes WD; Ragoussis J; Stamp GW; Allan GJ; Trowsdale J
Br J Cancer; 1993 Mar; 67(3):551-9. PubMed ID: 8094976
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.
Zhou CZ; Peng ZH; Zhang F; Qiu GQ; He L
World J Gastroenterol; 2002 Aug; 8(4):668-73. PubMed ID: 12174376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
